IL1B and neoplasm: Interestingly, the most abundant cytokine–receptor pair interaction between TAMs and tumor cells was predicted for IL1B and its decoy receptor IL1R2 (Fig. 2f and g), suggesting the inhibition of IL1B-mediated proinflammatory signaling by tumor cells.